Supernus Pharmaceuticals
SUPN
#4268
Rank
A$3.02 B
Marketcap
$54.15
Share price
0.77%
Change (1 day)
6.33%
Change (1 year)

P/S ratio for Supernus Pharmaceuticals (SUPN)

P/S ratio as of April 2025 (TTM): 2.77

According to Supernus Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.77. At the end of 2024 the company had a P/S ratio of 3.10.

P/S ratio history for Supernus Pharmaceuticals from 2012 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20243.1019.2%
20232.60-9.95%
20222.898.04%
20212.674.64%
20202.56-19.44%
20193.17-25.35%
20184.25-37.11%
20176.7616.17%
20165.8229.35%
20154.5016.32%
20143.87-84.58%
201325.1-83.1%
2012148

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
4.59 65.89%๐Ÿ‡บ๐Ÿ‡ธ USA
14.9 439.02%๐Ÿ‡บ๐Ÿ‡ธ USA
2.33-15.74%๐Ÿ‡บ๐Ÿ‡ธ USA
5.21 88.21%๐Ÿ‡บ๐Ÿ‡ธ USA
4.20 51.72%๐Ÿ‡บ๐Ÿ‡ธ USA